Agios Pharmaceuticals, Inc. (AGIO): Price and Financial Metrics
Agios Pharmaceuticals, Inc. (AGIO)
Today's Latest Price: $55.69 USD
0.05 (0.09%)
Updated Jul 2 4:00pm
Add AGIO to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
AGIO Stock Summary
- Of note is the ratio of Agios Pharmaceuticals Inc's sales and general administrative expense to its total operating expenses; just 13.04% of US stocks have a lower such ratio.
- With a price/sales ratio of 21.08, Agios Pharmaceuticals Inc has a higher such ratio than 93.11% of stocks in our set.
- Revenue growth over the past 12 months for Agios Pharmaceuticals Inc comes in at 50.87%, a number that bests 89.82% of the US stocks we're tracking.
- Stocks with similar financial metrics, market capitalization, and price volatility to Agios Pharmaceuticals Inc are BPMC, RARE, DRNA, PRNB, and RGNX.
- AGIO's SEC filings can be seen here. And to visit Agios Pharmaceuticals Inc's official web site, go to www.agios.com.
AGIO Daily Price Range
AGIO 52-Week Price Range
AGIO Stock Price Chart Technical Analysis Charts
AGIO Price/Volume Stats
| Current price | $55.69 | 52-week high | $56.74 |
| Prev. close | $55.64 | 52-week low | $27.77 |
| Day low | $55.09 | Volume | 678,488 |
| Day high | $56.74 | Avg. volume | 719,629 |
| 50-day MA | $48.23 | Dividend yield | N/A |
| 200-day MA | $43.15 | Market Cap | 3.84B |
Agios Pharmaceuticals, Inc. (AGIO) Company Bio
Agios Pharmaceuticals is focused on discovering and developing novel investigational medicines to treat cancer and rare genetic disorders of metabolism through scientific leadership in the field of cellular metabolism. The company was founded in 2007 and is based in Cambridge, Massachusetts.
Loading social stream, please wait...